This Weekly’s Hot Topics

  • Oncology Clinical Pathway Act of 2017 (AB1107) (California News)
  • ANCO Presidentmeetings reports (ANCO News)
  • May is skin cancer awareness month (National News)

ANCO/MOASC-sponsored legislation entitled the Oncology Clinical Pathway Act of 2017 (AB1107) would require health plans that choose to develop oncology clinical pathways to meet specific standards regarding those pathways and to divulge specific information to in-network providers upon request. For more information click here and go to California News.

There is Still Time to Evaluate Noridian’s Services! Share your experiences about the services Noridian provides. For more information click here and go to Noridian News.

MOASC Board of Directors has endorsed New Mexico medical oncologist, Barbara McAneny MD in her campaign for President-Elect of the American Medical Association (AMA).  MOASC asks members who are AMA members to reach out to their AMA delegates and encourage them to vote for Dr. McAneny for President-Elect in the June 2017 election. For more information click here and go to MOASC News.

The Community Oncology Alliance (COA) with the Community Oncology Pharmacy Association (COPA) have been heavily involved in fighting back on CVS Caremark’s decision to cease contracting with “Physician In-Office Dispensaries.” COPA is looking to see if there are any physician dispensing pharmacies that previously had been denied in the CVS/Caremark network to eventually getting approved to be in the CVS Caremark network this year. Below, is a letter from CVS Caremark to physicians regarding CVS Caremark’s current position. For more information click here and go to National News.

 

To view the complete California Oncology Weekly Newsletter click on the date below.

May 02, 2017